Letter to the Editor
Therapeutic approaches to multiple sclerosis in Central America and the Caribbean during the COVID-19 pandemic
Actitudes terapéuticas hacia la esclerosis múltiple en Centroamérica y el Caribe frente a la pandemia de SARS-CoV-2
Read
2879
Timeswas read the article
841
Total PDF
2038
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 141 | 23 | 164 |
| 2025 11 | 110 | 44 | 154 |
| 2025 10 | 90 | 31 | 121 |
| 2025 9 | 67 | 36 | 103 |
| 2025 8 | 58 | 14 | 72 |
| 2025 7 | 71 | 21 | 92 |
| 2025 6 | 38 | 11 | 49 |
| 2025 5 | 57 | 9 | 66 |
| 2025 4 | 42 | 7 | 49 |
| 2025 3 | 44 | 5 | 49 |
| 2025 2 | 40 | 9 | 49 |
| 2025 1 | 47 | 5 | 52 |
| 2024 12 | 20 | 7 | 27 |
| 2024 11 | 37 | 14 | 51 |
| 2024 10 | 28 | 11 | 39 |
| 2024 9 | 38 | 8 | 46 |
| 2024 8 | 29 | 7 | 36 |
| 2024 7 | 22 | 8 | 30 |
| 2024 6 | 22 | 5 | 27 |
| 2024 5 | 17 | 13 | 30 |
| 2024 4 | 19 | 166 | 185 |
| 2024 3 | 29 | 9 | 38 |
| 2024 2 | 28 | 10 | 38 |
| 2024 1 | 29 | 6 | 35 |
| 2023 12 | 30 | 10 | 40 |
| 2023 11 | 22 | 10 | 32 |
| 2023 10 | 37 | 4 | 41 |
| 2023 9 | 11 | 5 | 16 |
| 2023 8 | 23 | 3 | 26 |
| 2023 7 | 15 | 6 | 21 |
| 2023 6 | 10 | 3 | 13 |
| 2023 5 | 14 | 23 | 37 |
| 2023 4 | 30 | 3 | 33 |
| 2023 3 | 22 | 4 | 26 |
| 2023 2 | 16 | 9 | 25 |
| 2023 1 | 12 | 6 | 18 |
| 2022 12 | 18 | 5 | 23 |
| 2022 11 | 32 | 11 | 43 |
| 2022 10 | 23 | 13 | 36 |
| 2022 9 | 18 | 13 | 31 |
| 2022 8 | 27 | 15 | 42 |
| 2022 7 | 19 | 15 | 34 |
| 2022 6 | 19 | 12 | 31 |
| 2022 5 | 18 | 7 | 25 |
| 2022 4 | 39 | 7 | 46 |
| 2022 3 | 28 | 11 | 39 |
| 2022 2 | 30 | 4 | 34 |
| 2022 1 | 43 | 9 | 52 |
| 2021 12 | 34 | 7 | 41 |
| 2021 11 | 23 | 10 | 33 |
| 2021 10 | 25 | 9 | 34 |
| 2021 9 | 31 | 12 | 43 |
| 2021 8 | 44 | 7 | 51 |
| 2021 7 | 14 | 7 | 21 |
| 2021 6 | 14 | 8 | 22 |
| 2021 5 | 25 | 12 | 37 |
| 2021 4 | 73 | 11 | 84 |
| 2021 3 | 28 | 9 | 37 |
| 2021 2 | 11 | 13 | 24 |
| 2021 1 | 23 | 13 | 36 |
| 2020 12 | 14 | 25 | 39 |
| 2020 11 | 0 | 3 | 3 |
| 2020 10 | 0 | 8 | 8 |
Show all
